KREBSBIO — Krebs Biochemicals And Industries Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapMomentum Trap

Annual balance sheet for Krebs Biochemicals And Industries, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st	2026 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IAS	IAS	IAS	IAS	IAS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	0.323	0.174	0.691	0.234	0.109
Net Total Accounts Receivable
Net Total Receivables	90.4	31	66.8	30.5	27.7
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	355	161	174	103	96.2
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	1,442	1,487	1,495	1,465	1,430
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	1,898	1,750	1,782	1,690	1,632
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	781	491	618	1,035	1,131
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	2,649	2,744	2,974	3,153	3,260
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	-751	-995	-1,192	-1,462	-1,628
Total Liabilities & Shareholders' Equity	1,898	1,750	1,782	1,690	1,632
Total Common Shares Outstanding